UNCY – unicycive therapeutics, inc. (US:NASDAQ)

Sec Filings

Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Form 8-K Unicycive Therapeutics, For: Nov 14
Form 424B5 Unicycive Therapeutics,
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com